SCHEMBL7983700

SCHEMBL7983700

Cc1cc(Br)cc(Cl)c1Nc1nc2ccccc2n2cncc12

nearest known ligand 0.84

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LCK P06239 20/20 0.84

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7969626 0.92 LCK (0.82) LCK
SCHEMBL7987291 0.91 LCK (1.00) LCK
SCHEMBL7969709 0.84 LCK (1.00) LCK
SCHEMBL7981613 0.83 LCK (0.81) LCK
SCHEMBL7980228 0.83 LCK (0.81) LCK
SCHEMBL7969485 0.83 LCK (1.00) LCK
SCHEMBL7981489 0.82 LCK (0.73) LCK
SCHEMBL7970810 0.81 LCK (0.69) LCK
SCHEMBL7987777 0.81 LCK (0.73) LCK
SCHEMBL7980244 0.81 LCK (0.78) LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US claimed
WO-1999009845-A1 IMIDAZOQUINOXALINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-04 WO claimed
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US disclosed